KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Assets (2016 - 2025)

Quest Diagnostics' Assets history spans 17 years, with the latest figure at $16.2 billion for Q4 2025.

  • For Q4 2025, Assets changed 0.45% year-over-year to $16.2 billion; the TTM value through Dec 2025 reached $16.2 billion, changed 0.45%, while the annual FY2025 figure was $16.2 billion, 0.45% changed from the prior year.
  • Assets for Q4 2025 was $16.2 billion at Quest Diagnostics, roughly flat from $16.2 billion in the prior quarter.
  • Across five years, Assets topped out at $16.2 billion in Q4 2025 and bottomed at $12.8 billion in Q1 2023.
  • The 5-year median for Assets is $13.7 billion (2021), against an average of $14.2 billion.
  • The largest annual shift saw Assets fell 5.69% in 2022 before it grew 19.38% in 2024.
  • A 5-year view of Assets shows it stood at $13.6 billion in 2021, then fell by 5.69% to $12.8 billion in 2022, then rose by 9.23% to $14.0 billion in 2023, then grew by 15.2% to $16.2 billion in 2024, then rose by 0.45% to $16.2 billion in 2025.
  • Per Business Quant, the three most recent readings for DGX's Assets are $16.2 billion (Q4 2025), $16.2 billion (Q3 2025), and $16.0 billion (Q2 2025).